HK1257239A1 - Medicine for preventing and treating obesity and use of the medicine - Google Patents

Medicine for preventing and treating obesity and use of the medicine

Info

Publication number
HK1257239A1
HK1257239A1 HK18116275.2A HK18116275A HK1257239A1 HK 1257239 A1 HK1257239 A1 HK 1257239A1 HK 18116275 A HK18116275 A HK 18116275A HK 1257239 A1 HK1257239 A1 HK 1257239A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
treating obesity
obesity
treating
Prior art date
Application number
HK18116275.2A
Other languages
Chinese (zh)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257239A1 publication Critical patent/HK1257239A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18116275.2A 2016-12-15 2018-12-19 Medicine for preventing and treating obesity and use of the medicine HK1257239A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611161347 2016-12-15
CN201611162237 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257239A1 true HK1257239A1 (en) 2019-10-18

Family

ID=62656680

Family Applications (7)

Application Number Title Priority Date Filing Date
HK18116272.5A HK1257236A1 (en) 2016-12-15 2018-12-19 Medicine for preventing and treating hyperlipemia diseases and use of the medicine
HK18116273.4A HK1257237A1 (en) 2016-12-15 2018-12-19 Medicine for preventing and treating fatty liver and use of medicine
HK18116275.2A HK1257239A1 (en) 2016-12-15 2018-12-19 Medicine for preventing and treating obesity and use of the medicine
HK18116269.0A HK1257233A1 (en) 2016-12-15 2018-12-19 Medicine for preventing atherosclerosis and complications of atherosclerosis and use of medicine
HK18116270.7A HK1257234A1 (en) 2016-12-15 2018-12-19 Medicine for treating coronary atherosclerosis as well as complications of coronary atherosclerosis and use of the medicine
HK18116276.1A HK1257240A1 (en) 2016-12-15 2018-12-19 Medicine for preventing and treating tissue injury caused by abnormal fat deposition and use of the medicine
HK18116702.5A HK1257583A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating fat metabolism disorders and related diseases and use of the medicine

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK18116272.5A HK1257236A1 (en) 2016-12-15 2018-12-19 Medicine for preventing and treating hyperlipemia diseases and use of the medicine
HK18116273.4A HK1257237A1 (en) 2016-12-15 2018-12-19 Medicine for preventing and treating fatty liver and use of medicine

Family Applications After (4)

Application Number Title Priority Date Filing Date
HK18116269.0A HK1257233A1 (en) 2016-12-15 2018-12-19 Medicine for preventing atherosclerosis and complications of atherosclerosis and use of medicine
HK18116270.7A HK1257234A1 (en) 2016-12-15 2018-12-19 Medicine for treating coronary atherosclerosis as well as complications of coronary atherosclerosis and use of the medicine
HK18116276.1A HK1257240A1 (en) 2016-12-15 2018-12-19 Medicine for preventing and treating tissue injury caused by abnormal fat deposition and use of the medicine
HK18116702.5A HK1257583A1 (en) 2016-12-15 2018-12-28 Medicine for preventing and treating fat metabolism disorders and related diseases and use of the medicine

Country Status (2)

Country Link
CN (8) CN108210896A (en)
HK (7) HK1257236A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108671226A (en) * 2018-08-08 2018-10-19 广州铭康生物工程有限公司 The drug and application thereof of effective therapeutic community ductus venosus complication
CN110093412A (en) * 2019-03-29 2019-08-06 南方医科大学南方医院 For the molecular marker UGP2 of diagnosing atherosclerotic and application
CN111100928A (en) * 2020-01-09 2020-05-05 武汉科技大学 Atherosclerosis biomarker and atherosclerosis diagnosis kit
JP2023514819A (en) * 2020-02-26 2023-04-11 タレンゲン インターナショナル リミテッド Methods and drugs for preventing and treating hypertension
CN112305120B (en) * 2020-10-30 2022-02-08 河北医科大学第二医院 Application of metabolite in atherosclerotic cerebral infarction

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1408431A (en) * 2001-09-21 2003-04-09 北京华兴生生物技术有限公司 Gene engineering medicine for curing diseases relative to vascularization
AU2003210137A1 (en) * 2002-02-06 2003-09-02 N-Zyme Biotec Gmbh Method for producing recombinant proteins in micro-organisms
BR0311172A (en) * 2002-05-13 2005-04-26 Children S Hospital Los Angele Treatment and prevention of abnormal scarring in keloids and other internal or skin lesions or injuries
CN101518533A (en) * 2002-12-06 2009-09-02 法布罗根股份有限公司 Fat regulation
US7056943B2 (en) * 2002-12-10 2006-06-06 Wyeth Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
JPWO2005026127A1 (en) * 2003-09-11 2006-11-16 株式会社医薬分子設計研究所 Plasminogen activator inhibitor-1 inhibitor
ES2534744T3 (en) * 2004-04-22 2015-04-28 Grifols Therapeutics Inc. Recombinantly modified plasmin
WO2006095713A1 (en) * 2005-03-08 2006-09-14 Institute Of Medicinal Molecular Design. Inc. Inhibitor of plasminogen activator inhibitor-1
US20090123582A1 (en) * 2006-03-24 2009-05-14 Akiko Kuwahara Ameliorating Agent for Metabolic Syndrome
WO2008026999A2 (en) * 2006-08-28 2008-03-06 Omnio Healer Ab Candidates against infection
CA2666670A1 (en) * 2006-10-20 2008-05-02 Dow Global Technologies Inc. Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome
JP5470046B2 (en) * 2007-10-23 2014-04-16 株式会社医薬分子設計研究所 PAI-1 production inhibitor
US20090239868A1 (en) * 2007-10-23 2009-09-24 Institute Of Medical Molecular Design, Inc. Inhibitor of pai-1 production
NZ597452A (en) * 2009-07-10 2013-10-25 Thrombogenics Nv Variants of plasminogen and plasmin
CN102647994A (en) * 2009-08-12 2012-08-22 康奈尔大学 Methods for preventing or treating metabolic syndrome
EP2566890A4 (en) * 2010-05-03 2013-11-20 Abbvie Inc Anti-pai-1 antibodies and methods of use thereof
EP2661493B1 (en) * 2011-01-05 2016-03-30 ThromboGenics N.V. Plasminogen and plasmin variants
MX2013010076A (en) * 2011-03-03 2014-04-07 Tersus Pharmaceuticals Llc COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE.
CN102188699A (en) * 2011-05-06 2011-09-21 南京农业大学 Pharmaceutical composition for treating atherosclerosis, and preparation method and application thereof
US9644196B2 (en) * 2011-08-12 2017-05-09 Thrombogenics Nv Plasminogen and plasmin variants
CN102532326B (en) * 2011-11-18 2017-06-09 南京大学 A kind of human fiber plasminogen Kringle 5 variant of cancer target and its application
EA033403B1 (en) * 2013-08-13 2019-10-31 Sanofi Sa Antibodies to plasminogen activator inhibitor-1 (pai-1) and uses thereof
US20160199466A1 (en) * 2013-08-20 2016-07-14 Trustees Of Dartmouth College Methods For Treating Tissue Fibrosis

Also Published As

Publication number Publication date
CN108210895A (en) 2018-06-29
CN108210898A (en) 2018-06-29
HK1257236A1 (en) 2019-10-18
CN108210906A (en) 2018-06-29
CN108210902A (en) 2018-06-29
HK1257234A1 (en) 2019-10-18
CN108210914A (en) 2018-06-29
HK1257237A1 (en) 2019-10-18
CN108210900A (en) 2018-06-29
HK1257583A1 (en) 2019-10-25
HK1257240A1 (en) 2019-10-18
CN108210904A (en) 2018-06-29
CN108210896A (en) 2018-06-29
HK1257233A1 (en) 2019-10-18

Similar Documents

Publication Publication Date Title
IL277648A (en) Therapeutic microbiota for the treatment and/or prevention of food allergy
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
SI3227237T1 (en) Device and use thereof for the uv treatment of fluids
GB201411496D0 (en) Use of 7-Oh-Cannabidiol (7-Oh-CBD) and/or 7-Oh-Cannabidvarin (7-Oh-CBDV) in the treatment of epilepsy
IL290754A (en) Use of pridopidine for the treatment of anxiety and depression
HK1257239A1 (en) Medicine for preventing and treating obesity and use of the medicine
HK1259545A1 (en) Combination of bcl-2 inhibitor and mek inhibitor for the treatment of cancer
EP3544654C0 (en) Device for the repetitive supply and draining of substances for medical therapy
HK1249851A1 (en) Treatment and prevention of the common cold using povidone-iodine
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof
GB201617064D0 (en) Compounds and their therapeutic use
GB201715194D0 (en) Compounds and their therapeutic use
HK1257585A1 (en) Medicine for preventing and treating skin fibrosis and use of the medicine
IL272097A (en) Compounds for the prevention and treatment of medical disorders and uses thereof
EP3723742C0 (en) Use of fluoroethylnormemantine for the prevention and treatment of anxiety
EP3156054A4 (en) Medicine for preventing and/or treating stress-induced diseases
HK1257590A1 (en) Medicine for preventing and treating medicinal kidney injury and the use of the medicine
HK1257238A1 (en) Medicine for preventing and treating lipid kidney injury and use of the medicine
IL251135A (en) Method for the synthesis of hydroxy-triglycerides and use thereof for the prevention and treatment of diseases
PT3191112T (en) Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation
EP3490604C0 (en) Medicament for the treatment and/or prevention of endometriosis
GB201523012D0 (en) The combination of chinese medicine for treating infantile cough